Evidence map›Paper›PMID 33533030›Full record

ArticleThe EMBO journal2021

The RNA polymerase II subunit RPB-9 recruits the integrator complex to terminate Caenorhabditis elegans piRNA transcription.

Ahmet C Berkyurek, Giulia Furlan, Lisa Lampersberger, Toni Beltran, Eva-Maria Weick, Emily Nischwitz, Isabela Cunha Navarro, Fabian Braukmann, Alper Akay, Jonathan Price and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Identification of Reference Genes for RT-qPCR Assays inCurrent issues in molecular biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Ahmet C BerkyurekWellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-7546-9191
Giulia FurlanWellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-6134-6564
Lisa LampersbergerWellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3471-9908
Toni BeltranMRC London Institute of Medical Sciences, London, UK.ORCID 0000-0002-5949-2615
Eva-Maria WeickWellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3504-2572
Emily NischwitzQuantitative Proteomics, Institute of Molecular Biology, Mainz, Germany.
Isabela Cunha NavarroWellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-6844-2361
Fabian BraukmannWellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0003-2660-450X
Alper AkayWellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-6825-4443
Jonathan PriceWellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-6554-5667
Falk ButterQuantitative Proteomics, Institute of Molecular Biology, Mainz, Germany.ORCID 0000-0002-7197-7279
Peter SarkiesMRC London Institute of Medical Sciences, London, UK.ORCID 0000-0003-0279-6199
Eric A MiskaWellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-4450-576X
University of Cambridge · GBInstitute of Molecular Biology · DENIHR Imperial Biomedical Research Centre · GB

Funding

Cancer Research UK 18583Cancer Research UK 27826Cancer Research UK C13474/A18583Cancer Research UK C6946/A14492Medical Research Council MC_UP_1102/13Medical Research Council MR/S033769/1Wellcome TrustWellcome Trust 092096/Z/10/ZWellcome Trust 104640/Z/14/Z
6 · The paper itself

Abstract

PIWI-interacting RNAs (piRNAs) are genome-encoded small RNAs that regulate germ cell development and maintain germline integrity in many animals. Mature piRNAs engage Piwi Argonaute proteins to silence complementary transcripts, including transposable elements and endogenous genes. piRNA biogenesis mechanisms are diverse and remain poorly understood. Here, we identify the RNA polymerase II (RNA Pol II) core subunit RPB-9 as required for piRNA-mediated silencing in the nematode Caenorhabditis elegans. We show that rpb-9 initiates heritable piRNA-mediated gene silencing at two DNA transposon families and at a subset of somatic genes in the germline. We provide genetic and biochemical evidence that RPB-9 is required for piRNA biogenesis by recruiting the Integrator complex at piRNA genes, hence promoting transcriptional termination. We conclude that, as a part of its rapid evolution, the piRNA pathway has co-opted an ancient machinery for high-fidelity transcription.

Indexed as

Gene Expression RegulationGene SilencingTranscription, GeneticAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsGerm CellsPromoter Regions, GeneticProtein SubunitsRNA Polymerase IIRNA, Small InterferingCaenorhabditis elegans ProteinsProtein SubunitsRNA Polymerase IIRNA, Small InterferingintegratorpiRNAsRNA polymerase IIrpb-9transcription termination

Identifiers

PMID33533030
PMCPMC7917558
OpenAlexW3128378366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.